Details der Publikation - Challenges of Inpatient Blood Glucose Monitoring: Standards, Methods, and Devices to Measure Blood Glucose

Challenges of Inpatient Blood Glucose Monitoring: Standards, Methods, and Devices to Measure Blood Glucose

Abstract Glucose control in the hospital setting is very important. There is a high incidence of hyperglycemia, hypoglycemia, and glycemic variability in hospitalized patients. Safe insulin delivery and glucose control is dependent on reliable glucose meters and monitoring systems in the hospital. Different glucose monitoring systems use arterial, venous, central venous, and capillary blood samples. It is important for clinicians to be aware that there are limitations of specific point-of-care (POC) glucose meters and that situations exist whereby POC glucose meters as the sole measurement device should be avoided. POC meter devices are not approved by the Food and Drug Administration for use in critical care, although POC meter devices are commonly used in critical care settings and elsewhere. This review focuses on glucose assay principles, instrument technology, influences on glucose measurement, standards for glucose measurement, and an evaluation of different methods to measure blood glucose in the hospital setting..

Medienart:	E-Artikel

Erscheinungsjahr:	2015
Erschienen:	2015

Enthalten in:	Zur Gesamtaufnahme - volume:15
Enthalten in:	Current diabetes reports - 15(2015), 3 vom: 03. Feb.

Sprache:	Englisch

Beteiligte Personen:	Hermayer, Kathie L. [VerfasserIn] Loftley, Aundrea S. [VerfasserIn] Reddy, Sumana [VerfasserIn] Narla, Satya Nandana [VerfasserIn] Epps, Nina A. [VerfasserIn] Zhu, Yusheng [VerfasserIn]

Links:	Volltext [lizenzpflichtig]

BKL:	44.89$jEndokrinologie
Themen:	Arterial CLIA Calibration Capillary Continuous glucose monitoring Critical illness FDA Glucose HemoCue Hospital Hyperglycemia Hypoglycemia I-Stat Maltose Meter Point of care Venous Wired Wireless YSI

Anmerkungen:	© Springer Science+Business Media New York (outside the USA) 2015

doi:	10.1007/s11892-015-0582-9

funding:
Förderinstitution / Projekttitel:

PPN (Katalog-ID):	OLC210292372X

Internformat


LEADER	01000naa a22002652 4500
001	OLC210292372X
003	DE-627
005	20230402071708.0
007	cr uuu---uuuuu
008	230402s2015 xx \|\|\|\|\|o 00\| \|\|eng c
024	7		\|a 10.1007/s11892-015-0582-9 \|2 doi
035			\|a (DE-627)OLC210292372X
035			\|a (DE-He213)s11892-015-0582-9-e
040			\|a DE-627 \|b ger \|c DE-627 \|e rakwb
041			\|a eng
082	0	4	\|a 610 \|q VZ
084			\|a 44.89$jEndokrinologie \|2 bkl
100	1		\|a Hermayer, Kathie L. \|e verfasserin \|4 aut
245	1	0	\|a Challenges of Inpatient Blood Glucose Monitoring: Standards, Methods, and Devices to Measure Blood Glucose
264		1	\|c 2015
336			\|a Text \|b txt \|2 rdacontent
337			\|a Computermedien \|b c \|2 rdamedia
338			\|a Online-Ressource \|b cr \|2 rdacarrier
500			\|a © Springer Science+Business Media New York (outside the USA) 2015
520			\|a Abstract Glucose control in the hospital setting is very important. There is a high incidence of hyperglycemia, hypoglycemia, and glycemic variability in hospitalized patients. Safe insulin delivery and glucose control is dependent on reliable glucose meters and monitoring systems in the hospital. Different glucose monitoring systems use arterial, venous, central venous, and capillary blood samples. It is important for clinicians to be aware that there are limitations of specific point-of-care (POC) glucose meters and that situations exist whereby POC glucose meters as the sole measurement device should be avoided. POC meter devices are not approved by the Food and Drug Administration for use in critical care, although POC meter devices are commonly used in critical care settings and elsewhere. This review focuses on glucose assay principles, instrument technology, influences on glucose measurement, standards for glucose measurement, and an evaluation of different methods to measure blood glucose in the hospital setting.
650		4	\|a Glucose
650		4	\|a Meter
650		4	\|a Point of care
650		4	\|a Hyperglycemia
650		4	\|a Hypoglycemia
650		4	\|a Hospital
650		4	\|a Arterial
650		4	\|a Venous
650		4	\|a Capillary
650		4	\|a i-Stat
650		4	\|a HemoCue
650		4	\|a YSI
650		4	\|a Critical illness
650		4	\|a Calibration
650		4	\|a Continuous glucose monitoring
650		4	\|a Maltose
650		4	\|a Wired
650		4	\|a Wireless
650		4	\|a FDA
650		4	\|a CLIA
700	1		\|a Loftley, Aundrea S. \|4 aut
700	1		\|a Reddy, Sumana \|4 aut
700	1		\|a Narla, Satya Nandana \|4 aut
700	1		\|a Epps, Nina A. \|4 aut
700	1		\|a Zhu, Yusheng \|4 aut
773	0	8	\|i Enthalten in \|t Current diabetes reports \|d Springer US, 2001 \|g 15(2015), 3 vom: 03. Feb. \|h Online-Ressource \|w (DE-627)357168216 \|w (DE-600)2094158-4 \|w (DE-576)306830639 \|x 1539-0829 \|7 nnns
773	1	8	\|g volume:15 \|g year:2015 \|g number:3 \|g day:03 \|g month:02
856	4	0	\|u https://dx.doi.org/10.1007/s11892-015-0582-9 \|z lizenzpflichtig \|3 Volltext
912			\|a GBV_USEFLAG_A
912			\|a SYSFLAG_A
912			\|a GBV_OLC
912			\|a GBV_ILN_11
912			\|a GBV_ILN_20
912			\|a GBV_ILN_22
912			\|a GBV_ILN_23
912			\|a GBV_ILN_31
912			\|a GBV_ILN_32
912			\|a GBV_ILN_39
912			\|a GBV_ILN_40
912			\|a GBV_ILN_60
912			\|a GBV_ILN_62
912			\|a GBV_ILN_63
912			\|a GBV_ILN_65
912			\|a GBV_ILN_69
912			\|a GBV_ILN_70
912			\|a GBV_ILN_73
912			\|a GBV_ILN_74
912			\|a GBV_ILN_90
912			\|a GBV_ILN_95
912			\|a GBV_ILN_100
912			\|a GBV_ILN_101
912			\|a GBV_ILN_105
912			\|a GBV_ILN_110
912			\|a GBV_ILN_120
912			\|a GBV_ILN_138
912			\|a GBV_ILN_150
912			\|a GBV_ILN_151
912			\|a GBV_ILN_161
912			\|a GBV_ILN_170
912			\|a GBV_ILN_187
912			\|a GBV_ILN_213
912			\|a GBV_ILN_230
912			\|a GBV_ILN_285
912			\|a GBV_ILN_293
912			\|a GBV_ILN_370
912			\|a GBV_ILN_602
912			\|a GBV_ILN_636
912			\|a GBV_ILN_702
912			\|a GBV_ILN_2001
912			\|a GBV_ILN_2003
912			\|a GBV_ILN_2004
912			\|a GBV_ILN_2005
912			\|a GBV_ILN_2006
912			\|a GBV_ILN_2007
912			\|a GBV_ILN_2008
912			\|a GBV_ILN_2009
912			\|a GBV_ILN_2010
912			\|a GBV_ILN_2011
912			\|a GBV_ILN_2014
912			\|a GBV_ILN_2015
912			\|a GBV_ILN_2020
912			\|a GBV_ILN_2021
912			\|a GBV_ILN_2025
912			\|a GBV_ILN_2026
912			\|a GBV_ILN_2027
912			\|a GBV_ILN_2031
912			\|a GBV_ILN_2034
912			\|a GBV_ILN_2037
912			\|a GBV_ILN_2038
912			\|a GBV_ILN_2039
912			\|a GBV_ILN_2044
912			\|a GBV_ILN_2048
912			\|a GBV_ILN_2049
912			\|a GBV_ILN_2055
912			\|a GBV_ILN_2057
912			\|a GBV_ILN_2059
912			\|a GBV_ILN_2061
912			\|a GBV_ILN_2064
912			\|a GBV_ILN_2065
912			\|a GBV_ILN_2068
912			\|a GBV_ILN_2070
912			\|a GBV_ILN_2086
912			\|a GBV_ILN_2088
912			\|a GBV_ILN_2093
912			\|a GBV_ILN_2106
912			\|a GBV_ILN_2107
912			\|a GBV_ILN_2108
912			\|a GBV_ILN_2110
912			\|a GBV_ILN_2111
912			\|a GBV_ILN_2112
912			\|a GBV_ILN_2113
912			\|a GBV_ILN_2116
912			\|a GBV_ILN_2118
912			\|a GBV_ILN_2119
912			\|a GBV_ILN_2122
912			\|a GBV_ILN_2129
912			\|a GBV_ILN_2136
912			\|a GBV_ILN_2143
912			\|a GBV_ILN_2144
912			\|a GBV_ILN_2147
912			\|a GBV_ILN_2148
912			\|a GBV_ILN_2152
912			\|a GBV_ILN_2153
912			\|a GBV_ILN_2188
912			\|a GBV_ILN_2190
912			\|a GBV_ILN_2232
912			\|a GBV_ILN_2336
912			\|a GBV_ILN_2446
912			\|a GBV_ILN_2470
912			\|a GBV_ILN_2474
912			\|a GBV_ILN_2507
912			\|a GBV_ILN_2522
912			\|a GBV_ILN_2548
912			\|a GBV_ILN_4035
912			\|a GBV_ILN_4037
912			\|a GBV_ILN_4046
912			\|a GBV_ILN_4112
912			\|a GBV_ILN_4125
912			\|a GBV_ILN_4242
912			\|a GBV_ILN_4246
912			\|a GBV_ILN_4249
912			\|a GBV_ILN_4251
912			\|a GBV_ILN_4305
912			\|a GBV_ILN_4306
912			\|a GBV_ILN_4307
912			\|a GBV_ILN_4313
912			\|a GBV_ILN_4322
912			\|a GBV_ILN_4323
912			\|a GBV_ILN_4324
912			\|a GBV_ILN_4325
912			\|a GBV_ILN_4326
912			\|a GBV_ILN_4333
912			\|a GBV_ILN_4334
912			\|a GBV_ILN_4335
912			\|a GBV_ILN_4336
912			\|a GBV_ILN_4338
912			\|a GBV_ILN_4393
912			\|a GBV_ILN_4700
936	b	k	\|a 44.89$jEndokrinologie \|q VZ \|0 106410075 \|0 (DE-625)106410075
951			\|a AR
952			\|d 15 \|j 2015 \|e 3 \|b 03 \|c 02

Challenges of Inpatient Blood Glucose Monitoring: Standards, Methods, and Devices to Measure Blood Glucose

Zugang & Verfügbarkeit

Zugehörige Publikationen/Bände